Knee surgery with or without a meniscus transplant for knee osteoarthritis and misaligned legs
Compares knee osteotomy with and without meniscus transplant in people with knee osteoarthritis.
Key facts
- Who runs it
- Istituto Ortopedico Rizzoli
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Knee Osteotomy Associated With Allograft Meniscus Transplantation
- Status
- Recruiting
- People taking part
- 52 people, planned
- Started
- 30 Aug 2023
- Planned end
- Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Knee osteotomy associated with meniscal allograft transplantation
- Knee osteotomy
- Record updated
- 4 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with knee osteoarthritis in one part of the knee, a damaged or missing meniscus, and a misaligned leg. It compares knee osteotomy alone with osteotomy plus a donor meniscus.
- Age
- 20 to 60 years
- Sex
- Men and women
- Disease stage
- Osteoarthritis in one compartment of the knee, Kellgren-Lawrence grade ≤ 3. Leg axis deviation > 5° needing corrective osteotomy. Meniscus deficit on the overloaded side.
- Earlier treatment
- No knee surgery in the previous 12 months.
Main reasons for not taking part
- Cancer, rheumatoid arthritis, gout, other inflammatory arthritis, HIV infection, viral hepatitis or chondrocalcinosis
- Uncontrolled diabetes or uncontrolled thyroid disorders
- Body Mass Index > 40
- Pregnancy, breastfeeding or plans to become pregnant during the study
- Alcohol, drug or medication abuse, or neurological disorders that affect the study
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Male or female patients aged between 20 and 60 years
- Single-compartment tibiofemoral osteoarthritis (Kellgren-Lawrence grade ≤ 3)
- Surgical indication of corrective osteotomy (axial deviation of lower extremities > 5°)
- Meniscal deficit of the compartment affected by the overload due to malalignment
- Ability and consent of patients to actively participate in the rehabilitation protocol and clinical and radiological follow-up (RX and MRI)
- Signature of informed consent
Who cannot take part
- Patients abusing alcoholic beverages, drugs or medications
- Patients undergoing knee surgery in the previous 12 months
- Patients who are incapacitated or have neurological disorders that may invalidate the research protocol
- Diagnosis of neoplastic diseases
- Diagnosis of rheumatoid arthritis, Reiter's syndrome, psoriatic arthritis, gout, ankylosing spondylitis or arthritis resulting from another inflammatory disease; human immunodeficiency virus (HIV) infection, viral hepatitis; chondrocalcinosis
- Patients with uncontrolled diabetes mellitus
- Patients with uncontrolled thyroid metabolic disorders
- Body Mass Index > 40
- Pregnancy or lactation status or intention to become pregnant during the period of study participation
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 60 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a prospective randomized double-blind controlled clinical trial with parallel arms and 1:1 allocation.
Read full original descriptionShow less
The main objective of the BIOMAT project is to demonstrate, through an RCT, whether the combined approach by knee osteotomy and MAT can provide clinical improvement over knee osteotomy alone for the treatment of patients with monocompartmental knee OA associated with meniscal insufficiency and lower extremity malalignment. Secondary objectives are to demonstrate whether the addition of MAT to knee osteotomy in patients with monocompartmental OA can improve biomechanical parameters and whether this treatment has protective effects on the joint environment and cartilage degeneration.
The 2 groups in the trial
- Knee Ostetomy combined with meniscal allograft transplantationTreatment being tested
The treatment group will perform osteotomy and meniscal allograft transplantation to restore the meniscal deficiency.
Treatment: Knee osteotomy associated with meniscal allograft transplantation
- Knee OsteotomyExisting treatment, for comparison
The control group will consist of patients who will perform an isolated osteotomy.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Knee Osteotomy Associated With Allograft Meniscus Transplantation in Patients With Altered Mechanical Axis, Meniscectomy Outcomes, and Osteoarthritis: Clinical, Biomechanical, and Biological Evaluation
- Plain-language title
- Knee surgery with or without a meniscus transplant for knee osteoarthritis and misaligned legsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT05840887, who can take part
- Record updated
- 4 December 2025